Reports
Sale
Global Biosensors Market Share, Size, Analysis, Segmentation: By Product: Wearable, Non-Wearable; By Technology: Electrochemical, Optical, Piezoelectric, Thermal Biosensors, Nanomechanical; By Component: Bioreceptor Molecule, Biological Element, Transducer; By Application; By End User; Regional Analysis; Supplier Landscape; 2023-2031
Global Biosensors Market Outlook
The global biosensors market value was USD 7.5 billion in 2022, driven by the growing demand for point-of-care testing across the globe. The market size is anticipated to grow at a CAGR of 6.4% during the forecast period of 2023-2031 to achieve a value of USD 13.1 billion by 2031.
Wearable Segment to Account for a Substantial Share of the Global Biosensors Industry
Based on product, the wearable segment is expected to hold a significant share in the global biosensors industry in the forecast period. This growth can be attributed to the rising incidences of diabetes and cardiovascular diseases, which require regular monitoring and instant diagnostics. These are portable and allow people to have a home-based diagnosis, which is cost-effective and reduces the time required for the diagnosis. In addition, through wearable biosensors, patients can keep track of their real-time health situation, which helps in effective treatment and early detection of diseases, which could reduce the mortality risk.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Exhibit a Significant Growth in the Global Biosensors Industry
The North America region is predicted to occupy a considerable share of the global biosensors industry. This surge can be attributed to the increased implementation of biosensors in the region. In addition, this growth is due to the rising incidences of illnesses, which can be tracked and monitored by biosensors in the region, such as diabetes. According to the statistics provided by the American Diabetes Association, diabetes is the 7th primary cause of death in the United States, and around 1.5 million Americans are diagnosed with diabetes every year. In addition, the growing use of biosensors in the food and beverage industry has further boosted the market share of the region in the global biosensors industry.
Biosensors: Market Segmentation
Biosensors are self-containing analytical devices that are used to detect the presence of a biological analyte. It recognises the analyte and produces a measurable signal. The device comprises a transducer and a biological component such as an enzyme, which reacts upon interaction with a biological analyte. This biological reaction is converted into an electrical signal by the transducer. Biosensors are used in multiple ways and can, therefore, be referred to as immunosensor, optrodes, glucometers, biocomputers and biochips, among others. Some commonly found biosensors include store-bought pregnancy tests and glucose detectors.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is bifurcated into:
- Wearable
- Non-Wearable
On the basis of technology, the industry can be categorised into:
- Electrochemical
- Optical
- Piezoelectric
- Thermal Biosensors
- Nanomechanical
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Rapid Technological Advancements and the Rising Instances of Chronic Illnesses to Bolster the Growth of the Global Biosensors Industry
Biosensors are increasingly being utilised in biomedicine, food safety standards, defence , security, and environmental monitoring, and with rapid advancements, the biosensor devices have become extremely helpful in the healthcare sector. Emerging trends of nanotechnology-based biosensors have increased the sensitivity limit of biosensors. Furthermore, the rising spread of chronic diseases such as cancer, diabetes, and other cardiovascular diseases has increased the demand for biosensors in the market, such as biosensors for blood glucose monitoring, pregnancy tests, and cholesterol monitoring. In addition, with the advent of coronavirus and its rapid spread, consumers are investing in oximeters, which are biosensors that monitor oxygen and blood pressure levels. These are some of the factors that are expected to impact the overall growth of the biosensors industry positively.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Global Biosensors Market
The report gives a detailed analysis of the following key players in the global biosensors market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- AgaMatrix Holdings LLC
- Abott Laboratories Inc.
- Biosensors International Groups Ltd.
- Medtronic Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Technology |
|
| Breakup by Component |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biosensors Market Overview
3.1 Global Biosensors Market Historical Value (2016-2022)
3.2 Global Biosensors Market Forecast Value (2023-2031)
4 Global Biosensors Market Landscape
4.1 Global Biosensors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biosensors Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Biosensors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biosensors Market Segmentation
6.1 Global Biosensors Market by Product
6.1.1 Market Overview
6.1.2 Wearable
6.1.2.1 Wristwear
6.1.2.2 Eyewear
6.1.2.3 Footwear
6.1.2.4 Neckwear
6.1.2.5 Bodywear
6.1.2.6 Others
6.1.3 Non-Wearable
6.2 Global Biosensors Market by Technology
6.2.1 Market Overview
6.2.2 Electrochemical
6.2.2.1 Amperometric Sensor
6.2.2.2 Potentiometric Sensor
6.2.2.3 Conductometric Sensor
6.2.3 Optical
6.2.3.1 SPR
6.2.3.2 Colorimetric Biosensors
6.2.3.3 Fluorescence Biosensors
6.2.4 Piezoelectric
6.2.4.1 Acoustic Biosensors
6.2.4.2 Microcantilever Biosensors
6.2.5 Thermal Biosensor
6.2.6 Nanomechanical
6.3 Global Biosensors Market by Component
6.3.1 Market Overview
6.3.2 Bioreceptor Molecule
6.3.3 Biological Element
6.3.4 Transducer
6.4 Global Biosensors Market by Application
6.4.1 Market Overview
6.4.2 POC
6.4.2.1 Glucose Monitoring
6.4.2.2 Cardiac Marker
6.4.2.3 Infectious Disease Detection
6.4.2.4 Coagulation Monitoring
6.4.2.5 Pregnancy Testing
6.4.2.6 Blood Gas and Electrolyte Detection
6.4.2.7 Detection of Tumor or Cancer Marker
6.4.2.8 Urinalysis Testing
6.4.2.9 Cholesterol Testing
6.4.3 Home Diagnostic
6.4.3.1 Glucose Monitoring
6.4.3.2 Pregnancy Testing
6.4.3.3 Cholesterol Testing
6.4.4 Research Labs
6.4.5 Environmental Monitoring
6.4.6 Food and Beverages
6.4.7 Biodefence
6.5 Global Biosensors Market by End User
6.5.1 Market Overview
6.5.2 Home Healthcare Diagnostics
6.5.3 POC Testing
6.5.4 Food Industry
6.5.5 Research Laboratories
6.5.6 Security and Biodefence
6.6 Global Biosensors Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Bladder Cancer Treatment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Bladder Cancer Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Bladder Cancer Treatment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Bladder Cancer Treatment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Bladder Cancer Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 AgaMatrix Holdings LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Biosensors International Group, Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio-Rad Laboratories Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pinnacle Technologies Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Ercon, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Dupont Biosensors Materials
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Qtl Biodetection Llc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Molecular Devices Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Nova Biomedical
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Molex Llc
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Zimmer & Peacock As
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Siemens Healthcare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Biosensors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The biosensors market was valued at USD 7.5 billion in 2022.
The market is expected to grow at a CAGR of 6.4% from 2023 to 2031 to reach USD a value of USD 13.1 billion by 2031.
The major drivers of the market include the increased demand for biosensors like oximeters, the growing concerns of cancer and diabetes, favourable properties such as user-friendly interface and portability, rapidly growing geriatric population, and multifaceted application possibilities of the biosensor technology.
The key trends guiding the growth of the market include the rapid technological advancements and heightened investments in the R&D of biosensors technology.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product segments include wearable and non-wearable.
The major segments based on technology include electrochemical, optical, piezoelectric, thermal biosensors, and nanomechanical.
The major players in the market are AgaMatrix Holdings LLC, Abott Laboratories Inc., Biosensors International Groups Ltd., and Medtronic Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999$5999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER